TY - JOUR
KW - 3210:Psychological Disorders
KW - 3383:Drug & Alcohol Rehabilitation
KW - Adulthood (18 yrs & older)
KW - Affective Disorders
KW - article
KW - buprenorphine
KW - buprenorphine/naloxone treatment
KW - Comorbidity
KW - Drug Abuse
KW - Empirical Study
KW - Epidemiology
KW - Female
KW - Human
KW - Male
KW - Middle Age (40-64 yrs)
KW - mood disorders
KW - naloxone
KW - Opiates
KW - patients
KW - Prevalence
KW - primary care
KW - Primary Health Care
KW - psychiatric comorbidity
KW - Quantitative Study
KW - Substance use disorder
KW - substance use disorders
KW - Thirties (30-39 yrs)
KW - Treatment Outcome/Clinical Trial
KW - Young Adulthood (18-29 yrs)
AU - Jonathan D. Savant
AU - Declan T. Barry
AU - Christopher J. Cutter
AU - Michelle T. Joy
AU - An Dinh
AU - Richard S. Schottenfeld
AU - David A. Fiellin
A1 - 
BT - Drug and alcohol dependence
C5 - Opioids & Substance Use
CP - 1-3
IS - 1-3
JF - Drug and alcohol dependence
PB - Elsevier Science
PY - 2013
SN - 0376-8716, 0376-8716
SP - 243
EP - 247
EP - 
T1 - Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment
T2 - Drug and alcohol dependence
TI - Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment
U1 - Opioids & Substance Use
UR - http://search.proquest.com/docview/1327071869?accountid=28100
VL - 127
VO - 0376-8716, 0376-8716
Y1 - 2013
ER -